A raft of measures adopted by the US government to enhance the availability of drugs are impacting the margins of the Indian companies.Hyderabad-based Dr Reddy’s Laboratories (DRL) has said it expec...

The average consumer of medication in this country does not lose much sleep over drug quality or how drug regulators are doing their job. A new book out in the United States and now available here co...

Drug firm Wockhardt has for the first time in three years reported a consolidated net profit of Rs 19.21 crore for the December 2019 quarter mainly on account of an improvement in operational performa...

Wockhardt and Dr Reddy’s Laboratories have recast the terms of their Rs 1,850-crore deal for the sale of the former’s branded generic business because of the Covid-19 impact.In February this year,...

Hyderabad-based Dr Reddy’s Laboratories (DRL) is acquiring a part of the domestic branded business of Wockhardt for Rs 1,850 crore.DRL will acquire the select divisions of Wockhardt’s branded gene...

Drug majors Aurobindo Pharma and Dr Reddy’s Laboratories on Tuesday said they were preparing their legal defence to the charges of price fixing in the US market.As many as 49 US states have filed pr...

Shares of Hyderabad-based Dr Reddy’s Laboratories Ltd (DRL) on Friday dropped close to two per cent on the bourses over reports the US Food and Drugs Administration (US FDA) has issued eight observa...